Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/130571
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Metformin for preventing type 2 diabetes mellitus in women with a previous diagnosis of gestational diabetes: a narrative review |
Author: | Versace, V.L. Beks, H. Wesley, H. McNamara, K. Hague, W. Anjana, R.M. Mohan, V. Khunti, K. Dunbar, J.A. |
Citation: | Seminars in Reproductive Medicine, 2021; 38(6):366-376 |
Publisher: | Georg Thieme Verlag |
Issue Date: | 2021 |
ISSN: | 1526-4564 1526-4564 |
Statement of Responsibility: | Vincent L. Versace, Hannah Beks, Hannah Wesley, Kevin McNamara, William Hague, Ranjit Mohan Anjana ... et al. |
Abstract: | Women with a history of gestational diabetes mellitus (GDM) are at greater risk of developing type 2 diabetes mellitus (T2DM) when compared with women who have not had GDM. To delay or prevent T2DM, guidelines recommend regular screening in the primary care setting and lifestyle interventions that are largely focused on dietary and physical activity modifications. As the postpartum period can be challenging for women, uptake and engagement in screening and lifestyle interventions have been poor. Poor uptake and engagement places women with a history of GDM at heightened risk for future morbidity and development of T2DM. Metformin has been a longstanding and safe treatment for the control of blood glucose in people with T2DM. Research has supported the efficacy of metformin, used as an adjunct to a lifestyle intervention or as a stand-alone treatment, in preventing T2DM in people at high risk of T2DM. Findings from longitudinal studies have demonstrated the potential for metformin to reduce conversion to T2DM when used by women with a previous diagnosis of GDM. This review examines the potential effectiveness of metformin to reduce the incidence of T2DM among women with a previous diagnosis of GDM in the "real-world" setting. |
Keywords: | Gestational diabetes; type 2 diabetes mellitus; risk factors; preventive medicine; metformin |
Rights: | © 2021. Thieme. All rights reserved. |
DOI: | 10.1055/s-0041-1727203 |
Published version: | http://dx.doi.org/10.1055/s-0041-1727203 |
Appears in Collections: | Aurora harvest 8 Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.